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Abstract Migraine is the second most common headache
condition next to tension-type headache. Up to one fourth
of all women have migraine, and 20% of them experience
migraine without aura attack in at least two thirds of their
menstrual cycles. The current literature is analyzed in
response to the question of whether menstrual and non-
menstrual migraine attacks are different. The different
studies provide conflicting results, so it is not possible to
answer the question firmly. Future studies should be based
on the general population. Collection of both prospective
and retrospective data is warranted, and headache diagnosis
base on interviews by physicians with interest in headache
are more precise than lay interviews or questionnaires.
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Introduction
The appendix of the second edition of the International
Classification of Headache Disorders (ICHD-2) from 2004
describes two types of migraine without aura (MO) related
to menstruation: pure menstrual migraine (PMM) and
menstrually related migraine (MRM) [1]. Those with
PMM have MO attacks exclusively in relation to at least
two thirds of their menstrual periods, while those with
MRM additionally experience MO attacks outside the
menstrual period. Before the ICHD-2 classification,
researchers had no specific guidelines for the definition of
menstrualmigraine.ThefirstclassificationoftheInternational
Headache Society from 1988 did not classify menstrual
migraine as a specific type of headache, but had a comment
in relation to MO: “Migraine without aura may occur almost
exclusively at a particular time of the menstrual cycle—
so-called menstrual migraine. Generally accepted criteria for
thisentity arenot available. It seems reasonable to demandthat
90% of attacks should occur between 2 days before menses
and the last day of menses, but further epidemiological
knowledge is needed” [2]. The latter definition encompasses
only a few of those with MRM. A recent epidemiological
survey suggests that 21% of women with migraine have
menstrual migraine, and about two thirds have MRM [3￿].
These circumstances make the literature on menstrual
migraine heterogenous, which one should bear in mind in
the current analysis of symptomatology of menstrual and
nonmenstrual migraine attacks. To complicate matters, what
about migraine with aura (MA)? About one third of all
migraineurs have MA [4]. An epidemiological survey implies
that headache in attacks of MO may be slightly more severe
than headache in attacks of MA [5], but it seems that MA is
not associated with menstruation on the same scale as MO. In
fact, MA may be unrelated to menstruation [6].
The most precise information on migraine attacks is
ascertained from prospective recording (ie, headache diaries
with detailed information about pain characteristics,
accompanying symptoms, duration, and treatment). Such
data may not be generalizable because keeping a headache
diary for a longer period isnot applicable for a largepopulation
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large population-based studies may be generalizable, but the
detailed information about migraine attacks is subject to
memory bias. Thus, a combination of prospective and
retrospective data is likely to give the most precise description
of the migraine attacks.
This review analyzes the literature to enlighten whether
menstrual and nonmenstrual migraine attacks are different,
given the methodological challenges mentioned above.
Menstrual Versus Nonmenstrual Migraine Attacks
Attack Frequency
ADanishepidemiological surveybasedon18–to65-year-old
people from the general population, including a direct clinical
interview and a physical and neurological examination by a
physician, found that less than 10% of women with MO had
more than one MO attack per month [5].
Thus, the vast majority (ie, ≥90%) of all women with
migraine have 1 or fewer MO attacks per month. Some
of those with PMM will have 1 MO attack per month,
while most patients with MRM have more than 1 MO
attack per month. Thus, the MO attack frequency is
much higher in most women with PMM or MRM than in
those with nonmenstrual MO. Although this does not
address whether menstrual and nonmenstrual MO attacks
are different, it indicates that those with menstrual MO
are likely to have a higher disease burden than most
women with nonmenstrual MO.
Attack Severity
Pain Characteristics
Table 1 shows attack characteristics of menstrual migraine
in relation to nonmenstrual migraine. Two studies from the
general population suggest that the pain intensity is
higher in menstrual than nonmenstrual MO [7, 8].
Studies on clinic populations provide conflicting results;
four studies are in support of the findings in the general
population, while four studies suggest similar pain
intensity and one study missed information on pain
intensity [9–15, 16￿, 17￿].
Associated Symptoms
The study based on prospective filled-in diaries from the
general population suggests no significant difference in
associated symptoms in attacks of menstrual and non-
menstrual migraine [7]. This is supported by three studies
based on clinic populations [10, 15, 16￿]. However, two
clinic studies based on prospective filled-in diaries
suggest that menstrual migraine attacks are accompanied
by more nausea and vomiting than nonmenstrual attacks
[11, 14].
Duration
The study based on prospective filled-in diaries from the
general population suggests that attacks of menstrual and
nonmenstrual migraine have similar duration [7]. In
contrast, all the other studies suggest that attacks of
menstrual migraine are longer than attacks of nonmenstrual
migraine, including data based on prospective filled-in
diaries [8, 10, 16￿, 17￿].
Disability
The study based on prospective filled-in diaries from the
general population and one clinic study suggest that attacks
of menstrual and nonmenstrual migraine have similar
disability [7, 15]. In contrast, all the other studies suggest
that attacks of menstrual migraine are more disabling than
attacks of nonmenstrual migraine, including data based on
prospective filled-in diaries [8, 10, 12, 13, 16￿, 17￿].
Treatment
Two clinical trials on rizatriptan and almotriptan suggest
equal efficacy on pain relief 2 h post-treatment of menstrual
and nonmenstrual migraine attacks [9, 15]. Other studies
suggest that attacks of menstrual migraine are more
treatment resistant than attacks of nonmenstrual migraine
[8, 10, 16￿] or that menstrual migraine attacks are more
likely to relapse [17￿].
Conclusions
The question whether menstrual and nonmenstrual migraine
attacks are different unfortunately cannot be answered
unambiguously because previous studies provide conflicting
results. This is mainly due to different patient populations,
unequal definitions of menstrual migraine, and different
methods employed.
Future studies should focus on the general population to
providegeneralizabledata,incontrasttopossiblyskeweddata
from selected clinic populations. Prospective recordings
should be employed, combined with retrospective data on
the headache history. To provide precise headache diagnoses,
interviews by a trained physician or neurologist with special
interestinheadacheisthegoldstandard.Sucha studyislikely
to more firmly answer whether menstrual and nonmenstrual
migraine attacks are different.
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